20 weeks’ journey of US Market Entry Program is finally completed. The program is to provide soft landing for medical start-ups from Korea. 5 start-up cohorts, after competitive selection, have been fostered by BioHealth Innovation (BHI) and KOSME (Korea SMEs and Startups Agency).
The synergy between strong Korean Government support and local expertise delivered significant impact to us. Congratulations to 5 cohort start-ups for successfully achieved the mission !
{iframe}https://www.linkedin.com/feed/update/urn:li:activity:6988955738370899968/{/iframe}